Centro Nacional de Microbiología-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2015

  1. Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination

    Vaccine, Vol. 33, Núm. 42, pp. 5691-5699

2012

  1. Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains

    PLoS ONE, Vol. 7, Núm. 9

  2. Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 11, pp. 5534-5540

2011

  1. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2297-2302

2009

  1. Temporal trends of invasive streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007

    Journal of Clinical Microbiology, Vol. 47, Núm. 4, pp. 1012-1020

2008

  1. Decrease in bacterial load versus resistance selection of pneumococcal subpopulations by β-lactam physiological concentrations over time: An in vitro pharmacodynamic simulation

    Microbial Drug Resistance, Vol. 14, Núm. 1, pp. 13-21

2007

  1. Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states

    Clinical Microbiology and Infection, Vol. 13, Núm. 4, pp. 369-376

  2. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents

    International Journal of Antimicrobial Agents

2006

  1. Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: A pharmacodynamic in vitro model approach to selection of resistant populations

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 4, pp. 794-801

  2. Very high resistance to amoxicillin in Streptococcus pneumoniae: An epidemiological fact or a technical issue?

    Journal of Chemotherapy, Vol. 18, Núm. 3, pp. 303-306

2005

  1. Farmacodinamia de los betalactámicos y su modificación por el sistema inmunitario

    Revista Espanola de Quimioterapia

  2. Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae [1]

    Antimicrobial Agents and Chemotherapy

2004

  1. Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 11, pp. 4144-4147

2003

  1. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination

    Infection, Vol. 31, Núm. 1, pp. 51-54

2002

  1. Combined eirect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model [2]

    Antimicrobial Agents and Chemotherapy

  2. Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of β-lactams in a mouse sepsis model

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 5, pp. 1340-1344

  3. Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model

    Clinical and Experimental Immunology, Vol. 128, Núm. 3, pp. 411-415

  4. β-Lactam activity against resistant pneumococcal strains is enhanced by the immune system

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. SUPPL. 2, pp. 83-86

  5. β-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model

    Journal of Antimicrobial Chemotherapy, Vol. 49, Núm. 2, pp. 331-335

2001

  1. Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin [5]

    Journal of Antimicrobial Chemotherapy